Evidence map›Paper›PMID 40403105›Full record

ReviewCirculation research2025

Contributions of Noncardiac Organ-Heart Immune Crosstalk and Somatic Mosaicism to Heart Failure: Current Knowledge and Perspectives.

Marinos Kallikourdis, Jesse D Cochran, Kenneth Walsh, Gianluigi Condorelli

Abstract readReview
In one paragraph

Review in Circulation research, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 7 papers.

0numbers the graph read from it
0cells of the map it votes in
7citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

7 citing papers in PubMed.

  1. Article
  2. Review
  3. Review
  4. Article
  5. Article
  6. Article
  7. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

4 authors.

Marinos Kallikourdis *Department of Biomedical Sciences, Humanitas University, Pieve Emanuele (MI), Italy (M.K., G.C.).ORCID 0000-0001-9318-3368
Jesse D Cochran *Hematovascular Biology Center, Division of Cardiovascular Medicine and Robert M. Berne Cardiovascular Research Center (J.D.C., K.W.), University of Virginia School of Medicine, Charlottesville, VA.ORCID 0000-0001-9705-5785
Kenneth WalshHematovascular Biology Center, Division of Cardiovascular Medicine and Robert M. Berne Cardiovascular Research Center (J.D.C., K.W.), University of Virginia School of Medicine, Charlottesville, VA.ORCID 0000-0001-7580-2276
Gianluigi CondorelliDepartment of Biomedical Sciences, Humanitas University, Pieve Emanuele (MI), Italy (M.K., G.C.).ORCID 0000-0003-0481-6843

Funding

MEDICAL SCIENTIST TRAINING PROGRAMT32GM007267 · NIGMS · UNIVERSITY OF VIRGINIA CHARLOTTESVILLE · PI GARCIA-BLANCO, MARIANO A. · 1985 to 2024
$13.4M
Wnt signaling control of vascular phenotype in obesityR01HL142650 · NHLBI · BOSTON UNIVERSITY MEDICAL CAMPUS · PI GOKCE, NOYAN, WALSH, KENNETH · 2019 to 2023
$3.1M
Mosaic loss of Y chromosome in blood and heart failureR01AG073249 · NIA · UNIVERSITY OF VIRGINIA · PI WALSH, KENNETH · 2021 to 2025
$2.6M
Clonal hematopoiesis and accelerated metabolic dysfunction in obesityR01HL139819 · NHLBI · UNIVERSITY OF VIRGINIA · PI WALSH, KENNETH · 2019 to 2022
$2.1M
Role of therapy-related clonal hematopoiesis in anthracycline-induced cardiotoxicityR01HL152174 · NHLBI · UNIVERSITY OF VIRGINIA · PI WALSH, KENNETH · 2020 to 2024
$2.0M
Hematopoietic stem cell mutations and ischemic cardio-metabolic diseaseR01HL141256 · NHLBI · UNIVERSITY OF VIRGINIA · PI WALSH, KENNETH · 2019 to 2022
$1.9M
Mosaic Loss of the Y Chromosome in Cardiac AmyloidosisR01AG086508 · NIA · UNIVERSITY OF VIRGINIA · PI KENNETH WALSH · 2024 to 2026
$1.7M
Clonal hematopoiesis and severity of COVID-19 diseaseR21AG072095 · NIA · UNIVERSITY OF VIRGINIA · PI DEFILIPPI, CHRISTOPHER R, WALSH, KENNETH · 2021 to 2022
$457k
NHLBI NIH HHS R01 HL139819NHLBI NIH HHS R01 HL141256NHLBI NIH HHS R01 HL142650NHLBI NIH HHS R01 HL152174NIA NIH HHS R01 AG073249NIA NIH HHS R01 AG086508NIA NIH HHS R21 AG072095NIGMS NIH HHS T32 GM007267
6 · The paper itself

Abstract

Heart failure is the final outcome of most cardiovascular diseases and shares risk factors with other cardiovascular pathologies. Among these, inflammation plays a central role in disease progression and myocardial remodeling. Over the past 2 decades, numerous studies have explored immune-related mechanisms in cardiovascular disease, highlighting the importance of immune cross-talk between the heart and extra-cardiac organs, including bone marrow, spleen, liver, gut, and adipose tissue. This review examines how immune interactions among these organs contribute to heart failure pathogenesis, with a focus on clonal hematopoiesis, an age-related alteration of hematopoietic stem cells that fosters pathological bone marrow-heart communication. Additionally, we explore recent advances in the understanding of clonal hematopoiesis and its role in heart failure, emphasizing its implications for prognosis and potential therapeutic interventions. By integrating insights from immunology, metabolism, and aging, we provide a comprehensive perspective on the immunologic determinants of heart failure, paving the way for precision medicine approaches aimed at mitigating cardiovascular risk.

Indexed as

Heart FailureMosaicismAdipose TissueAnimalsClonal HematopoiesisHumansLiverSpleenbiomarkerscardiovascular diseasesclonal hematopoiesisheart failureimmunityprecision medicineprognosis

Identifiers

PMID40403105
PMCPMC12113531

What Socratic holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.